These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37462119)

  • 1. Systemic therapy in juvenile localized scleroderma.
    Foeldvari I; Marrani E
    Expert Rev Clin Immunol; 2023; 19(10):1225-1238. PubMed ID: 37462119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Li SC; Fuhlbrigge RC; Laxer RM; Pope E; Ibarra MF; Stewart K; Mason T; Becker ML; Hong S; Dedeoglu F; Torok KS; Rabinovich CE; Ferguson PJ; Punaro M; Feldman BM; Andrews T; Higgins GC;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):43. PubMed ID: 31307476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the Systemic Treatment of Pediatric Localized Scleroderma.
    Foeldvari I
    Paediatr Drugs; 2019 Dec; 21(6):461-467. PubMed ID: 31667717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
    Li SC; Torok KS; Ishaq SS; Buckley M; Edelheit B; Ede KC; Liu C; Rabinovich CE
    Rheumatology (Oxford); 2021 Aug; 60(8):3817-3825. PubMed ID: 33369667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
    Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
    Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.
    Lythgoe H; Almeida B; Bennett J; Bhat C; Bilkhu A; Brennan M; Deepak S; Dawson P; Eleftheriou D; Harrison K; Hawley D; Heaf E; Leone V; Long E; Maltby S; McErlane F; Rafiq N; Ramanan AV; Riley P; Rangaraj S; Varnier G; Wilkinson N; Pain CE
    Pediatr Rheumatol Online J; 2018 Dec; 16(1):80. PubMed ID: 30563543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma in children: an update.
    Zulian F; Cuffaro G; Sperotto F
    Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Juvenile localized scleroderma and its management.
    Li SC; Zheng RJ
    World J Pediatr; 2020 Feb; 16(1):5-18. PubMed ID: 31786801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?
    Valões CCM; Novak GV; Brunelli JB; Kozu KT; Toma RK; Silva CA
    Rev Bras Reumatol Engl Ed; 2017; 57(6):521-525. PubMed ID: 29173689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile localised scleroderma: a retrospective review of response to systemic treatment.
    Cox D; O' Regan G; Collins S; Byrne A; Irvine A; Watson R
    Ir J Med Sci; 2008 Dec; 177(4):343-6. PubMed ID: 18941862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.
    Zulian F; Martini G; Vallongo C; Vittadello F; Falcini F; Patrizi A; Alessio M; La Torre F; Podda RA; Gerloni V; Cutrone M; Belloni-Fortina A; Paradisi M; Martino S; Perilongo G
    Arthritis Rheum; 2011 Jul; 63(7):1998-2006. PubMed ID: 21305525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment in Juvenile Scleroderma.
    Zulian F; Tirelli F
    Curr Rheumatol Rep; 2020 Jun; 22(8):45. PubMed ID: 32591919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate.
    Inamo Y; Ochiai T
    Pediatr Dermatol; 2013; 30(6):e191-3. PubMed ID: 23025697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for morphea.
    Albuquerque JV; Andriolo BN; Vasconcellos MR; Civile VT; Lyddiatt A; Trevisani VF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005027. PubMed ID: 31309547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in Linear Scleroderma: Long-Term Efficacy in Fifty Children From a Single Pediatric Rheumatology Center.
    Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F; Martini G
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1259-1263. PubMed ID: 32433808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.
    Martini G; Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F
    Autoimmun Rev; 2018 Jul; 17(7):727-734. PubMed ID: 29729451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.
    Zulian F; Athreya BH; Laxer R; Nelson AM; Feitosa de Oliveira SK; Punaro MG; Cuttica R; Higgins GC; Van Suijlekom-Smit LW; Moore TL; Lindsley C; Garcia-Consuegra J; Esteves Hilário MO; Lepore L; Silva CA; Machado C; Garay SM; Uziel Y; Martini G; Foeldvari I; Peserico A; Woo P; Harper J;
    Rheumatology (Oxford); 2006 May; 45(5):614-20. PubMed ID: 16368732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes.
    Sung JJ; Chen TS; Gilliam AC; McCalmont TH; Gilliam AE
    J Am Acad Dermatol; 2011 Aug; 65(2):364-373. PubMed ID: 21570153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.